Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Turning to Goblet
View:
Post by westcoast1000 on May 29, 2023 6:47pm

Turning to Goblet

Althought we are in the last week of waiting about the Bracelet updated data on Saturday and then the kol talk on Monday,  I am also wondering about the other Goblet arms.

We are scheduled (based on the ONCY presentation to have updated results on first line panc in second half of 2023, while they are also waiting to give us some initial results for first and third line colorectal cancer, and anal cancer.

Do we know when these data will be released? Is there a conference at which they are planning to release this data? If so, when is that conference? What about abstracts etc? Have they been submitted?


Anyone with some information to pass on to all of us?

Roche now seems to be a very likely candidate for partnership/buyout. They have tecentriq which seems to work well with pela based on the initial panc results. Tecentriq is licensed for a vast array of cancers and accounts for about 12% of Roche's pharma revenues, IIRC.
Comment by askretka on May 29, 2023 8:50pm
ESMO Madrid Spain There' s a world GI conference earlier June or July but that's not the one.
Comment by westcoast1000 on May 29, 2023 9:20pm
Thanks, askretka. That is October 20-24 in Madrid. Abstracts have already been submitted (we hope by ONCY et al). It may be that the AIO constoritium of cancer researchers in Germany are submitting the abstract. So we wait some more. I figure by November we will pretty much know our future. 
Comment by fox7mf on May 29, 2023 9:34pm
November? We better have a damned good idea by post ASCO. 
Comment by Lesalpes29 on May 30, 2023 8:23am
An easy 2-3 $ 
Comment by Lesalpes29 on May 30, 2023 8:24am
Oups before the week-end. Maybe!
Comment by jimsenior on May 30, 2023 10:33am
GOBLET   -  On March 31, 2022. ONCY announced successful completion of the three-patient safety run-in for the third-line mCRC cohort of GOBLET. The first-line mCRC and anal cohorts did not require safety run-ins. I have 2 questions if anyone would care to answer. 1. Would Roche know the up to date status of GOBLET? Presumably Roche knows all about this trial with the fist around ...more  
Comment by jimsenior on May 30, 2023 12:48pm
TIGIT is an immune inhibitory receptor and plays a key role in the suppression of T-cell proliferation and activation. It is also involved in tumor cell evasion, and inhibits an antiviral immune response. Adding pelareorep to an anti-TIGIT like tiragolumab (Roche/Genentech) might be worth investigating.
Comment by Quentin30 on May 30, 2023 1:44pm
and by the time ONCY has assessed any potential synergy, the patent will be done... this MUST get approved in order to protect it.
Comment by jimsenior on May 30, 2023 2:20pm
@Q. Thank you for allowing the possibility of synergy. I thought of it while washing the mid-day dishes, and was not sure if an anti-TIGIT and pelareorep could even be a thing. Lay person. Was not sure about TIGIT inhibiting the antiviral response. AI will guide pharma. I no longer worry about patents as I am trusting that ONC/Y is fully and totally aware that they are getting bought out. To try ...more  
Comment by jimsenior on May 31, 2023 8:52am
To my Fellow Shareholders: One Marcus Antonius on yahoo has prophesied the following:   -  There is a 95% chance of ONCY going under and a 5% chance this company will ever put a drug on the market. Cavete a falsis prophetis!
Comment by Noteable on May 31, 2023 9:40am
If I recall correctly Mark Antony died by his own hand. Perhaps he should have consulted the oracles from the FDA on Accelerated Approval and drug approvals on surrogate endpoints before he acted on false prophesy.
Comment by Lesalpes29 on May 31, 2023 9:42am
Yahoo board is for poster like Angry101! Humour is like sentiment, it's really important in investing! GL
Comment by Buckhenry on May 30, 2023 3:00pm
If we had a dollar for every time these dreaming idiots have made an ignorant  stock prediction we could all retire rich 
Comment by Azzak34 on May 30, 2023 3:08pm
You ain't retiring rich idiot. 
Comment by ENEMENEMYNEMO on May 24, 2024 10:58am
Comment by ENEMENEMYNEMO on May 24, 2024 11:00am
See Pela....that's a daily affirmation 
Comment by Azzak34 on May 24, 2024 11:01am
RVV DOWN 96% SINCE THIS POST!!!!! 1...2...3.... BAHAHAHAHA by ENEMENEMYNEMOon Aug 16, 2022 11:45am 171 Views  Post# 34899527 Load up Picked up a bunch today! This is fantastic news, suprised the sp isn't skyrocketing today, I think the market doesn't understand the importance of the info in this NR. It's nuanced but it's ...more  
Comment by ENEMENEMYNEMO on May 24, 2024 11:17am
Yeah lost tonnnes here.  Much like ONC, holders were mislead by deceptive news releases and unscrupulous management. Matt is clearly doing the same.  The part you seem to miss here Azz  Wipes is that I'm trying to educate you dreamers on the faults of this company. My comments are purely pious, I know it's a difficult concept for you to grasp.  For ever yours ...more  
Comment by Azzak34 on May 24, 2024 11:23am
I'll let everyone speak for themselves but I think we're good thanks. Someone who has been so hilariously wrong so often has nothing to teach us. Some may be frustrated but most aren't ignorant.  I don't think you know what pious means! 
Comment by ENEMENEMYNEMO on May 24, 2024 11:24am
I don't think my Priest did either!
Comment by ENEMENEMYNEMO on May 24, 2024 11:48am
I'm done here. You guys are are too lacking in wit. Back  to your slapstick silliness.  Hehe you spelt spelled wrong Hehe
Comment by Noteable on May 24, 2024 11:52am
In UK English, both “spelled” and “spelt” are acceptable
Comment by ENEMENEMYNEMO on May 24, 2024 12:10pm
Not if you're making bread!!!! Hahaha okay now I'm done...
Comment by Noteable on May 24, 2024 12:23pm
Spelled vs.Spelt  Those who use loose expressions like "Hahahaha" obviously need a bit of tutoring in english, grammar and word definitions & origins. But hey, simple minds think simple things, like the gray vs. grey or check vs. cheque. https://www.grammarly.com/blog/spelled-spelt/
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse